Financhill
Buy
53

CLB Quote, Financials, Valuation and Earnings

Last price:
$18.25
Seasonality move :
7.15%
Day range:
$18.33 - $18.94
52-week range:
$13.82 - $25.13
Dividend yield:
0.22%
P/E ratio:
33.65x
P/S ratio:
1.69x
P/B ratio:
3.47x
Volume:
256.5K
Avg. volume:
306.7K
1-year change:
5.83%
Market cap:
$869M
Revenue:
$509.8M
EPS (TTM):
$0.55

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CLB
Core Laboratories
$134M $0.21 4.5% 433.33% $20.71
AROC
Archrock
$326.8M $0.31 25.88% 36.99% $26.75
BKR
Baker Hughes
$7.1B $0.63 3.89% 46.57% $46.75
NINE
Nine Energy Service
$135M -$0.24 -6.51% -33.33% $1.00
PED
PEDEVCO
$9.6M $0.01 48.9% 100% $1.95
TRGP
Targa Resources
$4.6B $1.81 9.73% 47.25% $194.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CLB
Core Laboratories
$18.51 $20.71 $869M 33.65x $0.01 0.22% 1.69x
AROC
Archrock
$25.36 $26.75 $4.4B 27.87x $0.18 2.64% 3.66x
BKR
Baker Hughes
$43.40 $46.75 $42.9B 19.46x $0.21 1.94% 1.60x
NINE
Nine Energy Service
$1.32 $1.00 $55.9M -- $0.00 0% 0.08x
PED
PEDEVCO
$0.85 $1.95 $75.7M 36.73x $0.00 0% 2.10x
TRGP
Targa Resources
$187.82 $194.75 $41B 33.96x $0.75 1.46% 2.58x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CLB
Core Laboratories
35.81% 1.749 15.98% 1.62x
AROC
Archrock
63.4% 2.046 63.07% 0.78x
BKR
Baker Hughes
27.16% 1.313 16.81% 0.75x
NINE
Nine Energy Service
122.06% 4.032 665.26% 1.50x
PED
PEDEVCO
-- -0.651 -- 1.95x
TRGP
Targa Resources
84.44% 1.805 40.83% 0.54x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CLB
Core Laboratories
$23.9M $15.6M 6.59% 10.93% 14.74% $10.4M
AROC
Archrock
$129.6M $95.5M 5.43% 15.16% 28.45% $26.9M
BKR
Baker Hughes
$1.5B $930M 10.26% 14.26% 15.4% $710M
NINE
Nine Energy Service
$15.7M $3.3M -15.34% -- 2.03% -$9.3M
PED
PEDEVCO
$3.4M $2.1M 2.3% 2.3% 23.16% $8.2M
TRGP
Targa Resources
$1.1B $728.2M 7.19% 28.18% 18.95% -$287.9M

Core Laboratories vs. Competitors

  • Which has Higher Returns CLB or AROC?

    Archrock has a net margin of 8.74% compared to Core Laboratories's net margin of 12.84%. Core Laboratories's return on equity of 10.93% beat Archrock's return on equity of 15.16%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLB
    Core Laboratories
    17.8% $0.25 $396.3M
    AROC
    Archrock
    44.35% $0.22 $3.5B
  • What do Analysts Say About CLB or AROC?

    Core Laboratories has a consensus price target of $20.71, signalling upside risk potential of 4.45%. On the other hand Archrock has an analysts' consensus of $26.75 which suggests that it could grow by 5.48%. Given that Archrock has higher upside potential than Core Laboratories, analysts believe Archrock is more attractive than Core Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLB
    Core Laboratories
    0 5 1
    AROC
    Archrock
    4 0 0
  • Is CLB or AROC More Risky?

    Core Laboratories has a beta of 2.388, which suggesting that the stock is 138.847% more volatile than S&P 500. In comparison Archrock has a beta of 1.584, suggesting its more volatile than the S&P 500 by 58.406%.

  • Which is a Better Dividend Stock CLB or AROC?

    Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.22%. Archrock offers a yield of 2.64% to investors and pays a quarterly dividend of $0.18 per share. Core Laboratories pays 5.09% of its earnings as a dividend. Archrock pays out 91.24% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CLB or AROC?

    Core Laboratories quarterly revenues are $134.4M, which are smaller than Archrock quarterly revenues of $292.2M. Core Laboratories's net income of $11.7M is lower than Archrock's net income of $37.5M. Notably, Core Laboratories's price-to-earnings ratio is 33.65x while Archrock's PE ratio is 27.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.69x versus 3.66x for Archrock. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLB
    Core Laboratories
    1.69x 33.65x $134.4M $11.7M
    AROC
    Archrock
    3.66x 27.87x $292.2M $37.5M
  • Which has Higher Returns CLB or BKR?

    Baker Hughes has a net margin of 8.74% compared to Core Laboratories's net margin of 11.09%. Core Laboratories's return on equity of 10.93% beat Baker Hughes's return on equity of 14.26%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLB
    Core Laboratories
    17.8% $0.25 $396.3M
    BKR
    Baker Hughes
    22.32% $0.77 $22.4B
  • What do Analysts Say About CLB or BKR?

    Core Laboratories has a consensus price target of $20.71, signalling upside risk potential of 4.45%. On the other hand Baker Hughes has an analysts' consensus of $46.75 which suggests that it could grow by 7.73%. Given that Baker Hughes has higher upside potential than Core Laboratories, analysts believe Baker Hughes is more attractive than Core Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLB
    Core Laboratories
    0 5 1
    BKR
    Baker Hughes
    14 5 0
  • Is CLB or BKR More Risky?

    Core Laboratories has a beta of 2.388, which suggesting that the stock is 138.847% more volatile than S&P 500. In comparison Baker Hughes has a beta of 1.396, suggesting its more volatile than the S&P 500 by 39.619%.

  • Which is a Better Dividend Stock CLB or BKR?

    Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.22%. Baker Hughes offers a yield of 1.94% to investors and pays a quarterly dividend of $0.21 per share. Core Laboratories pays 5.09% of its earnings as a dividend. Baker Hughes pays out 40.45% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CLB or BKR?

    Core Laboratories quarterly revenues are $134.4M, which are smaller than Baker Hughes quarterly revenues of $6.9B. Core Laboratories's net income of $11.7M is lower than Baker Hughes's net income of $766M. Notably, Core Laboratories's price-to-earnings ratio is 33.65x while Baker Hughes's PE ratio is 19.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.69x versus 1.60x for Baker Hughes. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLB
    Core Laboratories
    1.69x 33.65x $134.4M $11.7M
    BKR
    Baker Hughes
    1.60x 19.46x $6.9B $766M
  • Which has Higher Returns CLB or NINE?

    Nine Energy Service has a net margin of 8.74% compared to Core Laboratories's net margin of -7.34%. Core Laboratories's return on equity of 10.93% beat Nine Energy Service's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    CLB
    Core Laboratories
    17.8% $0.25 $396.3M
    NINE
    Nine Energy Service
    11.35% -$0.26 $260.9M
  • What do Analysts Say About CLB or NINE?

    Core Laboratories has a consensus price target of $20.71, signalling upside risk potential of 4.45%. On the other hand Nine Energy Service has an analysts' consensus of $1.00 which suggests that it could fall by -24.24%. Given that Core Laboratories has higher upside potential than Nine Energy Service, analysts believe Core Laboratories is more attractive than Nine Energy Service.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLB
    Core Laboratories
    0 5 1
    NINE
    Nine Energy Service
    0 0 1
  • Is CLB or NINE More Risky?

    Core Laboratories has a beta of 2.388, which suggesting that the stock is 138.847% more volatile than S&P 500. In comparison Nine Energy Service has a beta of 3.536, suggesting its more volatile than the S&P 500 by 253.637%.

  • Which is a Better Dividend Stock CLB or NINE?

    Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.22%. Nine Energy Service offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Core Laboratories pays 5.09% of its earnings as a dividend. Nine Energy Service pays out -- of its earnings as a dividend. Core Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CLB or NINE?

    Core Laboratories quarterly revenues are $134.4M, which are smaller than Nine Energy Service quarterly revenues of $138.2M. Core Laboratories's net income of $11.7M is higher than Nine Energy Service's net income of -$10.1M. Notably, Core Laboratories's price-to-earnings ratio is 33.65x while Nine Energy Service's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.69x versus 0.08x for Nine Energy Service. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLB
    Core Laboratories
    1.69x 33.65x $134.4M $11.7M
    NINE
    Nine Energy Service
    0.08x -- $138.2M -$10.1M
  • Which has Higher Returns CLB or PED?

    PEDEVCO has a net margin of 8.74% compared to Core Laboratories's net margin of 32.21%. Core Laboratories's return on equity of 10.93% beat PEDEVCO's return on equity of 2.3%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLB
    Core Laboratories
    17.8% $0.25 $396.3M
    PED
    PEDEVCO
    38% $0.03 $106.5M
  • What do Analysts Say About CLB or PED?

    Core Laboratories has a consensus price target of $20.71, signalling upside risk potential of 4.45%. On the other hand PEDEVCO has an analysts' consensus of $1.95 which suggests that it could grow by 112.77%. Given that PEDEVCO has higher upside potential than Core Laboratories, analysts believe PEDEVCO is more attractive than Core Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLB
    Core Laboratories
    0 5 1
    PED
    PEDEVCO
    1 0 0
  • Is CLB or PED More Risky?

    Core Laboratories has a beta of 2.388, which suggesting that the stock is 138.847% more volatile than S&P 500. In comparison PEDEVCO has a beta of 0.524, suggesting its less volatile than the S&P 500 by 47.628%.

  • Which is a Better Dividend Stock CLB or PED?

    Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.22%. PEDEVCO offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Core Laboratories pays 5.09% of its earnings as a dividend. PEDEVCO pays out -- of its earnings as a dividend. Core Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CLB or PED?

    Core Laboratories quarterly revenues are $134.4M, which are larger than PEDEVCO quarterly revenues of $9.1M. Core Laboratories's net income of $11.7M is higher than PEDEVCO's net income of $2.9M. Notably, Core Laboratories's price-to-earnings ratio is 33.65x while PEDEVCO's PE ratio is 36.73x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.69x versus 2.10x for PEDEVCO. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLB
    Core Laboratories
    1.69x 33.65x $134.4M $11.7M
    PED
    PEDEVCO
    2.10x 36.73x $9.1M $2.9M
  • Which has Higher Returns CLB or TRGP?

    Targa Resources has a net margin of 8.74% compared to Core Laboratories's net margin of 10.06%. Core Laboratories's return on equity of 10.93% beat Targa Resources's return on equity of 28.18%.

    Company Gross Margin Earnings Per Share Invested Capital
    CLB
    Core Laboratories
    17.8% $0.25 $396.3M
    TRGP
    Targa Resources
    29.37% $1.75 $18.4B
  • What do Analysts Say About CLB or TRGP?

    Core Laboratories has a consensus price target of $20.71, signalling upside risk potential of 4.45%. On the other hand Targa Resources has an analysts' consensus of $194.75 which suggests that it could grow by 5.64%. Given that Targa Resources has higher upside potential than Core Laboratories, analysts believe Targa Resources is more attractive than Core Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    CLB
    Core Laboratories
    0 5 1
    TRGP
    Targa Resources
    14 2 1
  • Is CLB or TRGP More Risky?

    Core Laboratories has a beta of 2.388, which suggesting that the stock is 138.847% more volatile than S&P 500. In comparison Targa Resources has a beta of 2.299, suggesting its more volatile than the S&P 500 by 129.914%.

  • Which is a Better Dividend Stock CLB or TRGP?

    Core Laboratories has a quarterly dividend of $0.01 per share corresponding to a yield of 0.22%. Targa Resources offers a yield of 1.46% to investors and pays a quarterly dividend of $0.75 per share. Core Laboratories pays 5.09% of its earnings as a dividend. Targa Resources pays out 31.75% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CLB or TRGP?

    Core Laboratories quarterly revenues are $134.4M, which are smaller than Targa Resources quarterly revenues of $3.9B. Core Laboratories's net income of $11.7M is lower than Targa Resources's net income of $387.4M. Notably, Core Laboratories's price-to-earnings ratio is 33.65x while Targa Resources's PE ratio is 33.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Core Laboratories is 1.69x versus 2.58x for Targa Resources. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CLB
    Core Laboratories
    1.69x 33.65x $134.4M $11.7M
    TRGP
    Targa Resources
    2.58x 33.96x $3.9B $387.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Cisco Systems Stock Be in 10 Years?
Where Will Cisco Systems Stock Be in 10 Years?

Cisco Systems, Inc. (NASDAQ:CSCO) has enjoyed its position as a…

Disney vs Estée Lauder Stock, Which Is Best?
Disney vs Estée Lauder Stock, Which Is Best?

Inflation has eaten away at a lot of the money…

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is down 0.23% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is up 4.97% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 8.78% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock